The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021–2023
Frontiers in Microbiology · 17.03.2025 · 16
DOI: 10.3389/fmicb.2025.1520864 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 17.03.2025. Verfasst von Rong Pei und 12 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Population Health, Infectious Disease Epidemiology Unit, National Perinatal Epidemiology Unit, University of Oxford, Oxford, U…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Liangshan Prefecture is one of the areas in China most severely affected by human immunodeficiency virus (HIV), but little is known about the molecular epidemiology of HIV-1 in this area. We aimed to analyze the distribution of HIV-1 genetic variants in Liangshan Prefecture in recent years.
Methods
8,523 blood samples were collected from people living with HIV with treatment failure and newly diagnosed individuals in all 17 counties and cities in Liangshan Prefecture between 2021 and 2023.
Results
The majority of study participants were male (66%), farmers (78%) and illiterate (53%). The main HIV-1 transmission routes were heterosexual contact (57%) and injecting drug use (27%). Among the 6,298 successfully obtained pol sequences the following HIV-1 variants were identified: CRF07_BC (93.9%), CRF08_BC (3.3%), CRF01_AE (1.4%), URFs (0.9%), CRF105_0108 (0.1%), CRF55_01B (0.1%), subtype B (0.1%), subtype C (0.1%), CRF88_BC (0.1%), CRF83_cpx (0.1%), CRF85_BC (0.03%), CRF67_01B (0.02%), CRF77_cpx (0.02%), and subtype A (0.02%). During the study period, the proportion of CRF07_BC gradually decreased, while other HIV-1 variants increased, a shift seen across all counties in Liangshan Prefecture. Newly diagnosed patients mainly acquired HIV through heterosexual transmission (86.7%), had a lower proportion of CRF07_BC (90.9%) and higher proportion of other HIV-1 variants, compared to treatment failure patients.
Conclusion
Future prevention and control policies need to take these changes into account.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nuffield Department of Population Health, Infectious Disease Epidemiology Unit, National Perinatal Epidemiology Unit, University of Oxford, Oxford, United Kingdom.
- School of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Sichuan Provincial Center for Disease Control and Prevention, Center for AIDS/STD Control and Prevention, Chengdu, China.
- Liangshan Prefecture Centre for Disease Control and Prevention, Xichang, Xichang, China.
Zitieren
APA
Pei, R., Su, L., Jike, C., Yu, G., Wang, J., Xiao, L., Wang, Y., Shen, M., Zhou, C., Liao, J., Zhang, Y., Zheng, Y., & Hemelaar, J. (2025). The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021–2023. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1520864
Vancouver
Pei R, Su L, Jike C, Yu G, Wang J, Xiao L, et al. The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021–2023. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1520864
BibTeX
@article{Pei2025,
author = {Pei, Rong and Su, Ling and Jike, Chunnong and Yu, Gang and Wang, Ju and Xiao, Lin and Wang, Yubing and Shen, Maogang and Zhou, Chang and Liao, Jiayi and Zhang, Yulian and Zheng, Yifei and Hemelaar, Joris},
title = {The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021–2023},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1520864}
}
EUVIMED